Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AI-mHRME for Esophageal Cancer Screening
NCT06435286Phase 2Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Feb 2025
- Primary completion
- Mar 2027
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Baylor College of Medicine. Primary endpoints: Clinical Impact at 18 months, Diagnostic Performance Characteristics at 18 months and 2 more. Started Feb 2025; status: recruiting.
02
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT06435286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06435286.